Trial intelligence / Profile preview

Vidofludimus + Methotrexate in Rheumatoid Arthritis

NCT01010581Phase 2Completed

Sponsor
4SC AG
Start
Nov 2009
Primary completion
Apr 2011
Modality
Small Molecules
Countries
4
01

Overview

A Phase 2 trial of vidofludimus calcium in rheumatoid arthritis (RA), sponsored by 4SC AG. Started Nov 2009; status: completed.

02

Drugs

vidofludimus calcium
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT01010581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01010581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call